Browsing Tag
Roche
88 posts
Roche reports setback in lung cancer study with tiragolumab and tecentriq combination
Roche (SIX: RO, ROG; OTCQX: RHHBY) has announced disappointing results from the phase II/III SKYSCRAPER-06 study, aimed at…
FDA approves Roche’s Vabysmo prefilled syringe for eye diseases, expanding treatment options for millions
Roche (SIX: RO, ROG; OTCQX: RHHBY), a global leader in pharmaceuticals and diagnostics, announced a significant advancement in…
Roche’s Columvi extends survival in Phase III DLBCL study
Roche has revealed promising outcomes from its Phase III STARGLO study, showcasing significant advancements in treating relapsed or…
LIXTE Biotechnology advances colon cancer treatment with Roche and Netherlands Cancer Institute
LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT and LIXTW), a trailblazer in clinical stage pharmaceutical development, has embarked on…
Roche and Hitachi High-Tech strengthen partnership with a renewed 10-year agreement
Roche and Hitachi High-Tech have announced a significant extension of their partnership, solidifying at least another decade of…
Roche’s CT-388 shows promising results in Phase I trial for obesity and Type 2 diabetes treatment
Roche has announced positive outcomes from the Phase I clinical trial of CT-388, a novel dual GLP-1/GIP receptor…
Roche gains FDA approval for HPV self-collection kit to enhance cervical cancer screening
Roche has achieved a significant milestone with the FDA approval of its innovative human papillomavirus (HPV) self-collection solution,…
Lonza to acquire Genentech’s biologics manufacturing facility in Vacaville for $1.2bn
In a strategic move that significantly escalates its capacity in the biologics manufacturing landscape, Lonza, a key global…
Roche to acquire LumiraDx’s Point of Care technology for $350m to expand diagnostics reach
Roche has announced a definitive agreement to acquire select parts of LumiraDx Group related to its innovative Point…
NiKang Therapeutics, Roche partner for advanced liver cancer treatment trial
NiKang Therapeutics Inc., a clinical-stage biotech company specializing in small molecule oncology medicines, has announced a significant clinical…